Trillium Therapeutics
Trillium Therapeutics Inc. - Trillium Home.
Launch date
Employees
Market cap
-
Enterprise valuation
€2.1b (Public information from Aug 2021)
Toronto Ontario (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
| N/A | N/A | IPO | |
| N/A | $1.0m | Early VC | |
* | N/A | $51.0m | Post IPO Equity |
N/A | - | ||
* | N/A | $30.0m | Post IPO Equity |
| N/A | $20.0m | Post IPO Equity | |
* | N/A | $25.0m | Post IPO Equity |
| N/A | $25.0m | Post IPO Equity | |
$25.0m | Post IPO Equity | ||
$2.3b Valuation: $2.3b | Acquisition | ||
| Total Funding | €909k | ||
Related Content
Recent News about Trillium Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.